Bristol Myers Squibb Chooses Houston for $2.3B Manufacturing Campus
Bristol Myers Squibb will build a $2.3 billion Generation Park manufacturing campus in Houston to produce small molecules, biologics, and antibody-drug conjugates. The modular, ~600,000-square-foot site can expand or reconfigure capacity as its pipeline changes, creating about 500 permanent jobs and roughly 2,000 construction and indirect jobs from 2027 to 2030. Separately, BMY and Hengrui Pharma structured a deal valued up to $15.2 billion with Janux conducting preclinical work and BMY taking on later clinical development and global